6.
Kumano O, Akatsuchi K, Amiral J
. Updates on Anticoagulation and Laboratory Tools for Therapy Monitoring of Heparin, Vitamin K Antagonists and Direct Oral Anticoagulants. Biomedicines. 2021; 9(3).
PMC: 7998518.
DOI: 10.3390/biomedicines9030264.
View
7.
Kanenawa K, Yamaji K, Tashiro H, Domei T, Ando K, Watanabe H
. Patient Selection and Clinical Outcomes in the STOPDAPT-2 Trial: An All-Comer Single-Center Registry During the Enrollment Period of the STOPDAPT-2 Randomized Controlled Trial. Circ Cardiovasc Interv. 2021; 14(2):e010007.
DOI: 10.1161/CIRCINTERVENTIONS.120.010007.
View
8.
Adams Jr H, Bendixen B, Kappelle L, Biller J, Love B, Gordon D
. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993; 24(1):35-41.
DOI: 10.1161/01.str.24.1.35.
View
9.
Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E
. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ. 2011; 183(16):1835-43.
PMC: 3216455.
DOI: 10.1503/cmaj.100912.
View
10.
Gutierrez-Arias R, Neculhueque-Zapata X, Valenzuela-Suazo R, Oliveros M, Morales C, Vasquez L
. Assessment of activities and participation of people by rehabilitation-focused clinical registries: a systematic scoping review. Eur J Phys Rehabil Med. 2023; 59(5):640-652.
PMC: 10664814.
DOI: 10.23736/S1973-9087.23.07895-4.
View
11.
Hirai T, Aoyama T, Tsuji Y, Itoh T, Matsumoto Y, Iwamoto T
. Kinetic-pharmacodynamic model of warfarin for prothrombin time-international normalized ratio in Japanese patients. Br J Clin Pharmacol. 2023; 90(3):828-836.
DOI: 10.1111/bcp.15967.
View
12.
Spinler S
. Adjusting the dose of low molecular weight heparins in renally impaired and obese patients. Clin Adv Hematol Oncol. 2005; 2(5):270, 273-4.
View
13.
Nakamura M, Yamashita T, Hayakawa A, Matsumoto T, Takita A, Hasegawa C
. Bleeding risks associated with anticoagulant therapies after percutaneous coronary intervention in Japanese patients with ischemic heart disease complicated by atrial fibrillation: A comparative study. J Cardiol. 2020; 77(2):186-194.
DOI: 10.1016/j.jjcc.2020.08.008.
View
14.
Nakamura M, Kadota K, Takahashi A, Kanda J, Anzai H, Ishii Y
. Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1-Year Results of the PENDULUM Registry. J Am Heart Assoc. 2020; 9(10):e015439.
PMC: 7660889.
DOI: 10.1161/JAHA.119.015439.
View
15.
Bauersachs R
. Fondaparinux Sodium: Recent Advances in the Management of Thrombosis. J Cardiovasc Pharmacol Ther. 2023; 28:10742484221145010.
DOI: 10.1177/10742484221145010.
View
16.
Nakamura M, Kadota K, Nakao K, Nakagawa Y, Shite J, Yokoi H
. High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry. EuroIntervention. 2020; 16(14):1154-1162.
PMC: 9725071.
DOI: 10.4244/EIJ-D-20-00345.
View
17.
Suppah M, Kamal A, Saadoun R, Baradeiya A, Abraham B, Alsidawi S
. An Evidence-Based Approach to Anticoagulation Therapy Comparing Direct Oral Anticoagulants and Vitamin K Antagonists in Patients With Atrial Fibrillation and Bioprosthetic Valves: A Systematic Review, Meta-Analysis, and Network Meta-Analysis. Am J Cardiol. 2023; 206:132-150.
DOI: 10.1016/j.amjcard.2023.07.141.
View
18.
Rautou P, Vion A, Amabile N, Chironi G, Simon A, Tedgui A
. Microparticles, vascular function, and atherothrombosis. Circ Res. 2011; 109(5):593-606.
DOI: 10.1161/CIRCRESAHA.110.233163.
View
19.
Kuriakose D, Xiao Z
. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. Int J Mol Sci. 2020; 21(20).
PMC: 7589849.
DOI: 10.3390/ijms21207609.
View
20.
Sun J, Ma Y, Su W, Miao H, Guo Z, Chen Q
. Comparison of anticoagulation monitoring strategies for adults supported on extracorporeal membrane oxygenation: A systematic review. Heart Lung. 2023; 61:72-83.
DOI: 10.1016/j.hrtlng.2023.05.003.
View